Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

CTN

Associated Studies:

Division Study Number Title Investigator(s) Release Date
CTN NIDA-CTN-0101 Subthreshold Opioid Use Disorder Prevention (STOP) Trial Jane Liebschutz, M.D., M.P.H., Jennifer McNeely, M.D.
CTN NIDA-CTN-0134 Identifying Regional “Hotspots” and Potential Correlates of Precipitated Withdrawal During Buprenorphine Induction in Fentanyl Users Through Prescriber Survey Responses and Patient Urine Drug Test Results (Buprenorphine-Precipitated Withdrawal Hotspots and Correlates) LaTrice Montgomery, Ph.D., T. John Winhusen, Ph.D.
CTN NIDA-CTN-0105 Integrating Pharmacy-Based Prevention and Treatment of Opioid and Other Substance Use Disorders: A Survey of Pharmacists and Stakeholders Li-Tzy Wu, ScD.
CTN NIDA-CTN-0095A1 Suicide Prediction and Prevention for People at Risk for Opioid Use Disorder Gavin Bart, Ph.D., M.D., Rebecca Rossom, M.D., M.S.
CTN NIDA-CTN-0083 Using Social Media to Deliver HIV Self-Testing Kits and Link to Online PrEP Services (Social Media PrEP) Jeffrey D. Klausner, M.D.
CTN NIDA-CTN-0069 Opioid Use Disorder in the Emergency Department (ED-HEALTH) David A. Fiellin, M.D., Gail D'Onofrio, M.D., M.S.
CTN NIDA-CTN-0097 Surmounting Withdrawal to Initiate Fast Treatment With Naltrexone (SWIFT) Adam Bisaga, M.D., Edward V. Nunes, M.D.
CTN NIDA-CTN-0081 Capturing Opioid Use Disorder Electronically & Patient Reported Outcomes (CODE-PRO) Arjun Krishna Venkatesh, MD, MBA, MHS, Kathryn Hawk, M.D., M.H.S., Richard Andrew Taylor, MD, MHS
CTN NIDA-CTN-0079 Emergency Department Connection to Care with Buprenorphine for Opioid Use Disorder (ED-CONNECT) John Rotrosen, M.D., Kathryn Hawk, M.D., M.H.S., Ryan McCormack, M.D.
CTN NIDA-CTN-0064 Assessing Long-term CTN-0049 Outcomes, HCV Prevalence and Progression along the HCV Care Continuum among HIV/HCV Co-infected Substance Users in the U.S. Carlos del Rio, M.D., Carmen Masson, Ph.D., Daniel J. Feaster, Ph.D., David Perlman, M.D., Lisa Metsch, Ph.D.
CTN NIDA-CTN-0095A2 Reducing Stigma toward People with Opioid Use Disorder among Primary Care Clinicians Stephanie Hooker, Ph.D., M.P.H., Rebecca Rossom, M.D., M.S., A. Lauren Crain, Ph.D., Gavin Bart, Ph.D., M.D.
CTN NIDA-CTN-0055 Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study (CHOICES) P. Todd Korthuis, MD
CTN NIDA-CTN-0051A2 Treatment-as-Usual Opioid Use Outcomes Following Discharge from Detoxification and Short-Term Residential Programs Affiliated with NIDA CTN-0051 John Rotrosen, M.D.
CTN NIDA-CTN-0067 Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up P. Todd Korthuis, MD
CTN NIDA-CTN-0093 Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool Gerald Cochran, PhD, T. John Winhusen, Ph.D.
CTN NIDA-CTN-0075 Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder Li-Tzy Wu, ScD., Paolo Mannelli, MD
CTN NIDA-CTN-0068 Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT-2) Madhukar H. Trivedi, M.D.
CTN NIDA-CTN-0054 Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT) Walter Ling, M.D.
CTN NIDA-CTN-0049 Project HOPE - Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users Lisa Metsch, Ph.D., Carlos del Rio, M.D.
CTN NIDA-CTN-0053 Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment (ACCENT) Kevin M. Gray, MD
CTN NIDA-CTN-0051 Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment John Rotrosen, M.D.
CTN NIDA-CTN-0059 The TAPS Tool: Screen and Brief Assessment Tool Validation Study Robert P Schwartz, M.D., Li-Tzy Wu, ScD., Jennifer McNeely, M.D.
CTN NIDA-CTN-0056 Testing and Linkage to HIV Care in China: A Cluster Randomized Trial Zunyou Wu, MD, PhD
CTN NIDA-CTN-0017 HIV and HCV Risk Reduction Interventions in Drug Detoxification and Treatment Settings Robert Booth, Ph.D.
CTN NIDA-CTN-0047 Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED) Michael P. Bogenschutz, M.D., Dennis Donovan, Ph.D.
CTN NIDA-CTN-0018 Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment Donald A. Calsyn, Ph.D.
CTN NIDA-CTN-0052 A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence (BRAC) T. John Winhusen, Ph.D.
CTN NIDA-CTN-0048 Cocaine Use Reduction with Buprenorphine (CURB) Walter Ling, M.D.
CTN NIDA-CTN-0046 Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes T. John Winhusen, Ph.D., Eugene Somoza, M.D.
CTN NIDA-CTN-0044 Web-delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders Edward V. Nunes, M.D.
CTN NIDA-CTN-0037 Stimulant Reduction Intervention using Dosed Exercise (STRIDE) Madhukar H. Trivedi, M.D.
CTN NIDA-CTN-AWARE Project Aware: HIV Rapid Testing & Counseling in STD Clinics in the U.S. – an Adaptation of CTN-0032 Lisa Metsch, Ph.D., Grant Colfax, M.D.
CTN NIDA-CTN-0032 HIV Rapid Testing and Counseling in Drug Abuse Treatment Programs in the U.S. Lisa Metsch, Ph.D.
CTN NIDA-CTN-0031A An Evaluation of Neurocognitive Function, Oxidative Damage, and Their Association With Treatment Outcomes in Methamphetamine and Cocaine Abusers T. John Winhusen, Ph.D., Eugene Somoza, M.D.
CTN NIDA-CTN-0031 Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement Dennis Donovan, Ph.D., Dennis Daley, Ph.D.
CTN NIDA-CTN-0030A3 Long-Term Follow-Up to CTN-0030 (A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence) Roger Weiss, M.D., Jennifer Sharpe Potter, Ph.D.
CTN NIDA-CTN-0030 A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence Walter Ling, M.D., Roger Weiss, M.D.
CTN NIDA-CTN-0029 A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers with ADHD T. John Winhusen, Ph.D., Eugene Somoza, M.D.
CTN NIDA-CTN-0028 Osmotic-Release Methylphenidate (OROS-MPH) for ADHD in Adolescents with Substance Use Disorders Paula Riggs, M.D.
CTN NIDA-CTN-0027 Starting Treatment with Agonist Replacement Therapies (START) Walter Ling, M.D.
CTN NIDA-CTN-0021 Motivational Enhancement Treatment to Improve Treatment Engagement and Outcome for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse Kathleen Carroll, Ph.D., José Szapocznik, Ph.D.
CTN NIDA-CTN-0020 Job Seekers Training for Patients with Drug Dependence Dace Svikis, Ph.D.
CTN NIDA-CTN-0019 Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment Susan Tross, Ph.D.
CTN NIDA-CTN-0016 Patient Feedback: A Performance Improvement Study in Outpatient Addiction Treatment Robert Forman, Ph.D.
CTN NIDA-CTN-0015 Women's Treatment for Trauma and Substance Use Disorders Denise Hien, Ph.D.
CTN NIDA-CTN-0014 Brief Strategic Family Therapy (BSFT) For Adolescent Drug Abusers José Szapocznik, Ph.D.
CTN NIDA-CTN-0013 Motivational Enhancement Therapy (MET) to Improve Treatment Utilization and Outcome in Pregnant Substance Users T. John Winhusen, Ph.D.
CTN NIDA-CTN-0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs Lawrence Brown, Jr., M.D., M.P.H.
CTN NIDA-CTN-0011 A Feasibility Study of a Telephone Enhancement Procedure (TELE) to Improve Participation in Continuing Care Activities Robert L. Hubbard, Ph.D., M.B.A.
CTN NIDA-CTN-0010 Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescents/Young Adults George Woody, M.D.
CTN NIDA-CTN-0009 Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs Malcolm Reid, Ph.D.
CTN NIDA-CTN-0008 Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation Dennis McCarty, Ph.D.
CTN NIDA-CTN-0007 Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics Maxine Stitzer, Ph.D.
CTN NIDA-CTN-0006 Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics Maxine Stitzer, Ph.D.
CTN NIDA-CTN-0005 MI (Motivational Interviewing) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse Kathleen Carroll, Ph.D.
CTN NIDA-CTN-0004 MET to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse Kathleen Carroll, Ph.D.
CTN NIDA-CTN-0003 Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules Walter Ling, M.D.
CTN NIDA-CTN-0002 Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification Walter Ling, M.D.
CTN NIDA-CTN-0001 Buprenorphine/Naloxone versus Clonidine for Inpatient Opiate Detoxification Walter Ling, M.D.
Subscribe to CTN